Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation

Cancer Research

Volumn 59, Issue 3, 1999, Pages 590-596

  Hecht, Stephen S ^a   Carmella, Steven G ^a   Chen, Menglan ^a   Dor Koch, J F ^a   Miller, Andrew T ^a   Murphy, Sharon E ^a   Jensen, Joni A ^c   Zimmerman, Cheryl L ^b   Hatsukami, Dorothy K ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CARCINOGENESIS; MALE; PRIORITY JOURNAL; SMOKING CESSATION; TOBACCO; TOXICOKINETICS; URINARY EXCRETION;

ADULT; ANIMALS; CARCINOGENS; COTININE; FEMALE; GLUCURONATES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NICOTINE; NITROSAMINES; RATS; RATS, INBRED F344; SMOKING CESSATION;

EID: 0033082421     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hecht, S. S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol., 11: 559-603, 1998.
2. Hecht, S. S., and Hoffmann, D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv., 8: 273-294, 1989.
3. Hecht, S. S., and Hoffmann, D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis (Lond.), 9: 875-884, 1988.
4. Maclure, M., Bryant, M. S., Skipper, P. L., and Tannenbaum, S. R. Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking. Cancer Res., 50: 181-184, 1990.
5. Mooney, L. A., Santella, R. M., Covey, L., Jeffrey, A. M., Bigbee, W., Randall, M. C. Cooper, T. M., Ottman, R., Tsai, W-Y., Wazneh, L., Glassman, A. H., Young, T-L., and Perera, F. P. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol. Biomark. Prev., 4: 627-634, 1995
6. Pulera, N., Petruzelli, S., Celi, A., Puntoni, R., Fornai, E., Sadie;we, O., Paoletti, P., and Giuntini, C. Presence and persistence of serum anti-benzo[a]pyrene diolepoxide-DNA adduct antibodies in smokers: effects of smoking reduction and cessation. Int. J. Cancer, 70: 145-149, 1997.
7. Priemé, H., Loft, S., Kharlund, M., Grønbaek, K., Tønnesen, P., and Poulsen, H. E. Effect of smoking cessation on oxidative DNA modification estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion. Carcinogenesis (Lond.), 19: 347-351, 1998.
8. Haley, N., Sepkovic, D., and Hoffmann, D. Elimination of cotinine from body fluids: disposition in smokers and nonsmokers. Am. J. Public Health, 79: 1046-1048, 1989.
9. Carmella, S. G., Akerkar, S., Richie, J. P., Jr., and Hecht, S. S. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol. Biomark. Prev., 4: 635-642, 1995.
10. Parsons, W. D., Carmella, S. G., Akerkar, S., Bonilla, L. E., and Hecht, S. S. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the urine of hospital workers exposed to environmental tobacco smoke. Cancer Epidemiol. Biomark. Prev., 7: 257-260, 1998.
11. 2 in humans. Biol. Mass Spectr., 20: 247-252, 1991.
12. Curvall, M., Elwin, C. E., Kazemi-Vala, E., Warholm, C. and Enzell, C. R. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur. J. Clin. Pharmacol., 38: 281-287, 1990.
13. Hecht, S. S., Trushin, N., Rigotty, J., Carmella, S. G., Borukhova, A., Akerkar, S. A., and Rivenson, A. Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. Cancer Epidemiol. Biomark. Prev., 5: 645-652, 1996.
14. Morse, M. A., Eklind, K. I., Toussaint, M., Amin, S. G., and Chung, F-L. Characterization of a glucuronide metabolite of 4-(methylmirosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis (Lond.), 11: 1819-1823, 1990.
15. Fisher, S., Spiegelhalder, B., and Preussmann, R. Influence of smoking parameters on the delivery of tobacco-specific nitrosamines in cigarette smoke: a contribution to relative risk evaluation. Carcinogenesis (Lond.), 10: 1059-1066, 1989.
16. Djordjevic, M. V., Hoffmann, D., and Hoffmann, I. Nicotine regulates smoking patterns. Prev. Med., 26: 435-440, 1997.
17. Evans, W. E., Schentag, J. J., and Jusko, W. J. (eds.). Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring, Ed. 3, pp 33-34. Vancouver, WA: Applied Therapeutics, Inc., 1992.
18. McEvoy, G. K. (ed.). American Hospital Formulary Service Drug Information 98, pp. 606, 1279. Bethesda: American Society of Health-System Pharmacists, Inc., 1998.
19. Castonguay, A., Tjälve, H., and Hecht, S. S. Tissue distribution of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its metabolites in F344 rats. Cancer Res., 43: 630-638, 1983.
20. Castonguay, A., Tjälve, H., Trushin, N., and Hecht, S. S. Perinatal metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in C57B1 mice. J. Natl. Cancer Inst. (Bethesda), 72: 1117-1126, 1984.
21. Tjälve, H., and Castonguay, A. The in vivo tissue disposition and in vitro target-tissue metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in Syrian golden hamsters. Carcinogenesis (Lond.), 4: 1259-1265, 1983.
22. Castonguay, A., Tjälve, H., Trushin, N., d'Argy, R., and Sperber, G. Metabolism and tissue distribution of tobacco-specific N-nitrosamines in the marmoset monkey (Callithrix jacchus). Carcinogenesis (Lond.), 6: 1543-1550, 1985.
23. Tjälve, H. The tissue distribution and the tissue specificity of bioactivation of some tobacco-specific and some other N-nitrosamines. Crit. Rev. Toxicol., 21: 265-294, 1991.
24. 14C in tissues of the mouse. Drug Metab. Dispos., 4: 530-539, 1976.
25. Larsson, B., and Tjälve, H. Studies on the mechanism of drug-binding to melanin. Biochem. Pharmacol., 28: 1181-1187, 1979.
26. Gerde, P., Muggenburg, B. A., Stephens, T., Lewis, J. L., Pyon, K. H., and Dahl, A. R. A relevant dose of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is extensively metabolized and rapidly absorbed in the canine tracheal mucosa. Cancer Res., 58: 1417-1422, 1998.
27. Carmella, S., Borukhova, A., Desai, D., and Hecht, S. S. Evidence for endogenous formation of tobacco-specific nitrosamines from nicotine and other tobacco alkaloids in rats. Carcinogenesis (Lond.), 18: 101-106, 1997.